Lixte Biotech Hlds
(LIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,982 | -971 | -5,087 | -4,055 | -3,036 |
| Accounts payable and accrued liabilities | -25 | 90 | -74 | -9 | 137 |
| Other Working Capital | 7 | 79 | -48 | -6 | 32 |
| Other Operating Activity | 392 | 13 | 916 | 678 | 420 |
| Operating Cash Flow | $-1,608 | $-789 | $-4,293 | $-3,391 | $-2,447 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 3,143 | 3,143 | 6 |
| Financing Cash Flow | $N/A | $N/A | $3,143 | $3,143 | $6 |
| Beginning Cash Position | 4,204 | 4,204 | 5,353 | 5,353 | 5,353 |
| End Cash Position | 2,595 | 3,414 | 4,204 | 5,106 | 2,913 |
| Net Cash Flow | $-1,608 | $-789 | $-1,150 | $-248 | $-2,441 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,608 | -789 | -4,293 | -3,391 | -2,447 |
| Free Cash Flow | -1,608 | -789 | -4,293 | -3,391 | -2,447 |